[FATE] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -6.05%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 4,106 4,402 2,431 0 971 2,670 1,170 23.25%
PBT -42,952 -33,462 -29,992 -25,883 -20,894 -14,239 -13,427 21.36%
Tax 297 -743 -677 53 796 487 127 15.19%
NP -42,952 -33,462 -29,992 -25,883 -20,894 -14,239 -13,427 21.36%
Tax Rate - - - - - - - -
Total Cost 47,058 37,864 32,423 25,883 21,865 16,909 14,597 21.52%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -1,046.08 -760.15 -1,233.73 0.00 -2,151.80 -533.30 -1,147.61 -1.53%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -1.02 -1.05 -1.18 -1.27 -3.54 -1.61 -1.51 -6.32%
EPS Diluted -1.02 -1.05 -1.18 -1.27 -3.54 -1.61 -1.51 -6.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.